US 12049505
Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof
granted A61KA61K2039/505A61K38/00
Quick answer
US patent 12049505 (Matrix metalloprotease-cleavable and serine or cysteine protease-cleavable substrates and methods of use thereof) held by CytomX Therapeutics, Inc. expires Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- CytomX Therapeutics, Inc.
- Grant date
- Tue Jul 30 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 25 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K2039/505, A61K38/00, A61P, A61P35/00